Search Results - "Burkhardt UE"

Serving up whatever you wish: CRISPR-base editing generates novel cancer-restricted antigens for immunotherapy.

Authors: Burkhardt UE Fritsch EF

Source: Genes and immunity [Genes Immun] 2023 Dec; Vol. 24 (6), pp. 292-294. Date of Electronic Publication: 2023 Dec 11.

Publication Type: Journal Article; Comment

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100953417 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5470 (Electronic) Linking ISSN: 14664879 NLM ISO Abbreviation: Genes Immun Subsets: MEDLINE

Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved.

Authors: Fritsch EF Burkhardt UE Hacohen N et al.

Source: Cancer immunology research [Cancer Immunol Res] 2020 Dec; Vol. 8 (12), pp. 1465-1469.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Haematological malignancies: at the forefront of immunotherapeutic innovation.

Authors: Bachireddy P Burkhardt UE Rajasagi M et al.

Source: Nature reviews. Cancer [Nat Rev Cancer] 2015 Apr; Vol. 15 (4), pp. 201-15. Date of Electronic Publication: 2015 Mar 19.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124168 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1768 (Electronic) Linking ISSN: 1474175X NLM ISO Abbreviation: Nat Rev Cancer Subsets: MEDLINE

Toward the next waves of cancer immunotherapy: 11th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Mainz, Germany, May 14-16, 2013.

Authors: Kloke BP Rae R Mahr A et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2014 Jul; Vol. 63 (7), pp. 749-55. Date of Electronic Publication: 2013 Nov 05.

Publication Type: Conference Proceedings; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

Boosting leukemia-specific T cell responses in patients following stem cell transplantation.

Authors: Burkhardt UE Wu CJ

Source: Oncoimmunology [Oncoimmunology] 2013 Nov 01; Vol. 2 (11), pp. e26587. Date of Electronic Publication: 2013 Oct 10.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells.

Authors: Burkhardt UE Hainz U Stevenson K et al.

Source: The Journal of clinical investigation [J Clin Invest] 2013 Sep; Vol. 123 (9), pp. 3756-65. Date of Electronic Publication: 2013 Aug 05.

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

CD40L-Tri, a novel formulation of recombinant human CD40L that effectively activates B cells.

Authors: Naito M Hainz U Burkhardt UE et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2013 Feb; Vol. 62 (2), pp. 347-57. Date of Electronic Publication: 2012 Aug 25.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cells.

Authors: Burkhardt UE Sloots A Jakobi V et al.

Source: Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2012 Sep; Vol. 61 (9), pp. 1473-84. Date of Electronic Publication: 2012 Feb 14.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE

A cloning and expression system to probe T-cell receptor specificity and assess functional avidity to neoantigens.

Authors: Hu Z Anandappa AJ Sun J et al.

Source: Blood [Blood] 2018 Nov 01; Vol. 132 (18), pp. 1911-1921. Date of Electronic Publication: 2018 Aug 27.

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood